Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 4

Risk factors for bacteremia in children with febrile neutropenia

Pages
1198–1205
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These factors can predict bacteremia in childrenwith FN.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Bacteremia remains an important cause of morbidity and mortality during febrile neutropenia (FN) episodes.
📊
Key Findings & Data:Weaimed to define the risk factors for bacteremia in febrile neutropenic children with hemato-oncological malignancies.Materials and methods: The records of 150 patients aged ≤18 years who developed FN in hematology and oncology clinics wereretrospectively evaluated.
💡
Conclusion & Impact:These factors can predict bacteremia in childrenwith FN.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Bacteremia remains an important cause of morbidity and mortality during febrile neutropenia (FN) episodes. Weaimed to define the risk factors for bacteremia in febrile neutropenic children with hemato-oncological malignancies.Materials and methods: The records of 150 patients aged ≤18 years who developed FN in hematology and oncology clinics wereretrospectively evaluated. Patients with bacteremia were compared to patients with negative blood cultures.Results: The mean age of the patients was 7.5 ± 4.8 years. Leukemia was more prevalent than solid tumors (61.3% vs. 38.7%). Bacteremiawas present in 23.3% of the patients. Coagulase-negative staphylococci were the most frequently isolated microorganism. Leukopenia,severe neutropenia, positive peripheral blood and central line cultures during the previous 3 months, presence of a central line, previousFN episode(s), hypotension, tachycardia, and tachypnea were found to be risk factors for bacteremia. Positive central line culturesduring the previous 3 months and presence of previous FN episode(s) were shown to increase bacteremia risk by 2.4-fold and 2.5-fold,respectively.Conclusion: Presence of a bacterial growth in central line cultures during the previous 3 months and presence of any previous FNepisode(s) were shown to increase bacteremia risk by 2.4-fold and 2.5-fold, respectively. These factors can predict bacteremia in childrenwith FN.

🔖

Cite This Article

KARA, S. S., YARALI, N., KAYA, Z., YÜKSEK, S. K., KOÇAK, Ü., DEMİRDAĞ, T. B., TAPISIZ, A., FETTAH, A., ÖZBEK, N., POLAT, M., YENİCESU, İ., YAYLA, B. C. C., OKUR, A., TEZER, H. (2022). Risk factors for bacteremia in children with febrile neutropenia. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 4, 1198–1205. https://ajindex.com/articles/609955

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clinical Infectious Diseases 2007; 45: 1296-1304
  2. Akova M, Alp S. Management of febrile neutropenia in the era of bacterial resistance. Therapeutic Advances in Infectious Diseases 2013; 1: 37-43
  3. Santolaya ME, Farfán MJ, De La Maza V, Cociña M, Santelices F et al. Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer. Pediatric Infectious Diseases Journal 2011; 30: 957-961
  4. Wildi K, Tschudin-Sutter S, Dell-Kuster S, Frei R, Bucher HC et al. Factors associated with positive blood cultures in outpatients with suspected bacteremia. European Journal of Clinical Microbiology & Infectious Diseases 2011; 30: 1615- 1619
  5. Stabell N, Nordal E, Stensvold E, Gammelsrud KW, Lund B et al. Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome. Scandinavian Journal of Infectious Diseases 2008; 40: 301-307
  6. Lücking V, Rosthøj S. Prediction of bacteremia in children with febrile episodes during chemotherapy for acute lymphoblastic leukemia. Pediatric Hematology and Oncology 2013; 30: 131- 140
  7. Orudjev E, Lange BJ. Evolving concepts of management of febrile neutropenia in children with cancer. Medical and Pediatric Oncology 2002; 39: 77-85
  8. Ha YE, Song JH, Kang WK, Peck KR, Chung DR et al. Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy. Supportive Care in Cancer. 2011; 19: 1761-1767
  9. Lucas KG, Brown AE, Armstrong D, Chapman D, Heller G. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996; 77: 791-798
  10. Rondinelli PI, Ribeiro Kde C, de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. Journal of Pediatric Hematology and Oncology 2006; 28: 665-670
  11. Santolaya ME, Alvarez AM, Becker A, Cofre J, Enriquez N et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. Journal of Clinical Oncology 2001; 19: 3415-3421
  12. Mian A, Becton D, Saylors R, James L, Tang X et al. Biomarkers for risk stratificat